SAHA, a HDAC1 inhibitor, significantly increased the protein level of acetylated H3 protein in all tested PCa cells, showing the inhibition efficiency on HDAC, but no effect on the levels of PARP and HDAC1 (Fig. 6a). This evidence concerns the gene HDAC1 and posterior cortical atrophy.